FibroGen is a venture capital fund based in San Francisco, California, founded in 1993 The firm focuses on investing in innovative biotechnology and pharmaceutical companies With a significant investment scale of $145,800,000, FibroGen aims to support the development of breakthrough therapies The fund is dedicated to advancing healthcare solutions that address unmet medical needs Through strategic...